Corn dried distillers grains with solubles (cDDGS) in the diet of pigs change the expression of adipose genes that are potential therapeutic targets in metabolic and cardiovascular diseases

BMC Genomics. 2018 Dec 3;19(1):864. doi: 10.1186/s12864-018-5265-x.

Abstract

Background: Corn dried distillers grains with solubles (cDDGS) are a byproduct of biofuel and alcohol production. cDDGS have been used in pig feed for many years, because they are readily available and rich in protein, fiber, unsaturated fatty acids and phytosterols. However, feed mixtures too high in cDDGS result in the worsening of backfat quality. We performed RNA-sequencing analysis of backfat from crossbred pigs fed different diets. The diets were isoenergetic but contained different amounts of cDDGS and various sources of fats. The animals were divided into four dietary groups during the two months of experimentation: group I (control (-cDDGS+rapeseed oil)), group II (+cDDGS+rapeseed oil), group III (+cDDGS+beef tallow), and group IV (+cDDGS+coconut oil). The aim of the present experiment was to evaluate changes in the backfat transcriptome of pigs fed isoenergetic diets that differed in cDDGS presence.

Results: Via DESeq2 software, we identified 93 differentially expressed genes (DEGs) between groups I and II, 13 between groups I and III, and 125 between groups I and IV. DEGs identified between group I (-cDDGS+rapeseed oil) and group II (+cDDGS+rapeseed oil) were highly overrepresented in several KEGG pathways: metabolic pathways (FDR < 1.21e-06), oxidative phosphorylation (FDR < 0.00189), fatty acid biosynthesis (FDR < 0.00577), Huntington's disease (FDR < 0.00577), fatty acid metabolism (FDR < 0.0112), Parkinson's disease (FDR < 0.0151), non-alcoholic fatty liver disease (NAFLD) (FDR < 0.016), Alzheimer's disease (FDR < 0.0211) and complement and coagulation cascades (FDR < 0.02).

Conclusions: We observed that the addition of cDDGS positively affects the expression of several genes that have been recently proposed as potential targets for the treatment of obesity, diabetes, cardiovascular disease, and Alzheimer's disease (e.g., FASN, AACS, ALAS1, HMGCS1, and VSIG4). Thus, our results support the idea of including cDDGS into the diets of companion animals and humans and encourage research into the bioactive ingredients of cDDGS.

Keywords: Alzheimer’s; Backfat; CVD; Metabolic diseases; Obesity; Pigs; RNA-seq; cDDGS.

MeSH terms

  • 5-Aminolevulinate Synthetase / genetics
  • 5-Aminolevulinate Synthetase / metabolism
  • Adipose Tissue / drug effects
  • Adipose Tissue / metabolism*
  • Animal Feed / analysis
  • Animals
  • Cardiovascular Diseases / diet therapy*
  • Cardiovascular Diseases / genetics
  • Cardiovascular Diseases / metabolism
  • Diet*
  • Edible Grain / metabolism
  • Fatty Acid Synthase, Type I / genetics
  • Fatty Acid Synthase, Type I / metabolism
  • Gene Expression Regulation / drug effects
  • Metabolic Diseases / diet therapy*
  • Metabolic Diseases / genetics
  • Metabolic Diseases / metabolism
  • Oxidative Phosphorylation / drug effects
  • Plant Oils / pharmacology
  • Protein Interaction Maps
  • RNA / chemistry
  • RNA / isolation & purification
  • RNA / metabolism
  • Receptors, IgE / genetics
  • Receptors, IgE / metabolism
  • Sequence Analysis, RNA
  • Swine
  • Zea mays / metabolism*

Substances

  • Plant Oils
  • Receptors, IgE
  • RNA
  • 5-Aminolevulinate Synthetase
  • Fatty Acid Synthase, Type I